ICAP

IMPOWER 22

A Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Pre-Exposure Prophylaxis in Cisgender Women at High Risk for HIV-1 Infection.


ICAP CTU

Status

Upcoming

Locations

Our Approach

Research

Health Challenges

HIV/AIDS

Keywords

CTU